Functional influenza virus-like particles (VLPs)

Details for Australian Patent Application No. 2004268510 (hide)

Owner Novavax, Inc.

Inventors Pushko, Peter M.; Robinson, Robin A.

Agent Allens Arthur Robinson

Pub. Number AU-B-2004268510

PCT Pub. Number WO2005/020889

Priority 10/617,569 11.07.03 US

Filing date 9 July 2004

Wipo publication date 10 March 2005

Acceptance publication date 9 June 2011

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

C07K 14/11 (2006.01) Peptides having more than 20 amino acids

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/020889 Priority application(s): WO2005/020889

9 June 2011 Application Accepted

  Published as AU-B-2004268510

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268513-Monoclonal antibodies against ricin toxin and methods of making and using thereof

2004268506-Control of protozoa and protozoan cysts that harbor Legionella